Iron(III) acetylacetonate (Fe(acac) 3 , 99.9%), oleylamine (>70%), diphenyl ether (99%), 
Experimental

Preparation of Magnetite Nanoparticles.
Fe (acac) 3 (3 mmol) was dissolved in 10 mL of diphenyl ether and 20 mL of oleylamine. The solution was dehydrated at 110 o C for 1 h under N 2 atmosphere, then quickly heated to 300 o C at a heating rate of 20 o C/ min, and aged at this temperature for 1 h. After the reaction, the solution was allowed to cool down to room temperature. The Fe 3 O 4 nanoparticles were extracted upon the addition of 50 mL of ethanol, followed by centrifuging and drying at 60 o C under vacuum.
Functionalization of Magnetite Nanoparticles.
The as-prepared Fe 3 O 4 nanoparticles (140 mg) were dispersed in 20 mL of diphenyl ether to form a colloid solution by sonication. Methyl 3-mercaptopropionate (33 μL ) was then added to the colloid solution and refluxed at ~ 259 o C for 1 h. Subsequently, the solution was cooled to 100 o C and 145 μL of hydrazine monohydrate (N 2 H 4 •H 2 O) was added dropwise to the solution, while continuously stirring the solution for 2 h. The resulting nanoparticles were separated by centrifuging at 15,000 rpm for 10 min, washed with methanol, and dried at 60°C under vacuum for 24 h. As a consequence of the above procedure, the Fe 3 O 4 nanoparticles functionalized with -NHNH 2 group on the surface (Fe 3 O 4 -NHNH 2 ) were obtained.
Synthesis of Fe 3 O 4 -DOX nanoparticles
The Fe 3 O 4 -NHNH 2 nanoparticles (100 mg) were dispersed by sonication in 20 mL of methanol containing 0.5 mL of acetic acid to form a colloid solution. Doxorubicin (10.3 mg) was then added to the colloid solution while stirring. The reaction was carried out at room temperature for 48 h. The resulted DOX-loaded magnetite nanoparticles (Fe 3 O 4 -DOX) were isolated with a Nd-Fe-B magnet and washed with methanol until the supernatant became colorless, and finally 
In vitro drug release experiment
Fe 3 O 4 -DOX nanoparticles and Fe 3 O 4 -DOX/pSiO 2 -PEG were suspended, respectively, in 4 mL PBS buffer (pH=7.4) with a concentration of 0.1 mg/mL at 37 o C under constant stirring. The solution pH was adjusted by titration of 1.0 M HCl to achieve pH values of 5. After incubation for 1, 2, 3, 5, 8, 12, 24, 36, 48 and 72h , the nanoparticle suspensions were centrifuged at 3000 rpm to isolate the nanoparticles from the released DOX and PBS solutions. The released DOX was analyzed by monitoring the absorbance at 482 nm, and the amount was determined by the calibration curve of DOX in PBS (C μg/mL =42.7758Abs+0.2244), range from 0 to 25 μg/mL with R 2 =0.9999.
Intracellular release of DOX from the nanocarriers
The HeLa and A549 cells were cultured in 12-well plates (1×10 5 cells per well)
overnight, then the culture medium was replaced with fresh culture medium containing drug carrier particles and incubated in a fully humidified atmosphere at 37 0 C containing 5% CO 2 , respectively. The final concentration of DOX cultured with cells was all at 5 µg mL -1 . After 1-12 hours treatment, the medium was replaced with PBS and the fluorescence of DOX in the cells were observed under a fluorescence microscope.
11.Cytotoxicity of the prepared drug carrier nanoparticles
To determine cytotoxicity/viability, the HeLa cells were plated at a density of 1×10 4 cells/well in a 96-well plate at 37 o C in 5% CO 2 atmosphere. After 24 h of culture, the medium in the wells was replaced with the fresh medium containing the nanoparticles of varying concentrations. After 24h, 20μL of MTT dye solution (5 mg/mL in phosphate buffer pH 7.4) was added to each well. After 4 h of incubation at 37 o C in 5% CO 2 for exponentially growing 
Characterization
Morphology and structure of the nanoparticles were characterized by using a Tecnai-G20 transmission electron microscope (TEM). Samples for TEM were prepared by placing a drop of water dispersion onto a carbon-coated copper grid and dried at room temperature. Fourier transform infrared (FTIR) spectra were collected with a Thermo Nicolet 6700 spectrophotometer with a resolution of 4 cm -1 . The samples for FTIR measurement were prepared by dispersing of the nanoparticles in a KBr pellet. N 2 adsorption-desorption isotherms, and pore-size distributions were obtained using a Micromeritics ASAP 2020 analyzer at 77K. Prior to measurements, samples were degassed at 180 o C for 12 h. Uv-vis spectra were recorded on a Lambda 25 UV-vis spectrophotometer. Cell lines were cultured with a water-jacketed CO 2 incubator (Thermo 3111).
Cells were visualized by a Nikon TI-E fluorescent microscope. The crystallographic data were obtained on an X'Pert-Pro MRD X-ray diffractometer with Cu Kα radiation (I =1.5418 Å). The magnetic property was measured on a Lakeshore 7300 vibrating sample magnetometer at room temperature. Contact angle of the nanoparticles was measured using a Dataphysics OCA20 contact-angle system at ambient temperature. Absorbance in the MTT assay was read by a Biotek Elx 800 microplate reader.
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Supporting Figures   Fig.S1 shows the XRD pattern of the as-prepared Fe 3 O 4 nanoparticles. All diffraction peaks in the XRD pattern of the as-prepared magnetite nanoparticles can be easily indexed to be a pure cubic inverse spinel structure, which matches well with the reported data (JCPDS: 65-3107), In addition, the bands due to C-H stretching mode in the range from 2800 to 3000 cm -1 become significantly weak, indicating a change of the hydrocarbon chain length from C 18 (oleylamine) to C 3 (HSCH 2 CH 2 CONHNH 2 ). Taken together, the Fe 3 O 4 nanoparticles are successfully functionalized with a hydrazide end-group, convenient for grafting of DOX in the next step.
Similarly, FTIR results also confirm the conjugation of DOX to magnetic nanoparticles via reaction of hydrazide groups of the Fe 3 O 4 -SCH 2 CH 2 CONHNH 2 with carbonyl groups of DOX (Fig.S2c) . A feature peak at 1630 cm -1 is assigned to -C=N-bonds resulting from the reaction of hydrazide group of the Fe 3 O 4 -SCH 2 CH 2 CONHNH 2 with carbonyl group at the 13-keto position of DOX. The characteristic bands at 1714 cm -1 , 1588 cm -1 and 1280 cm -1 correspond to DOX. They are ascribed to the stretching vibration of unreacted carbonyl group at the 13-keto position, the stretching vibration of carbonyl groups located at the anthracene ring and the skeleton vibration of DOX molecule, respectively. While the other characteristic bands outlined in Fig.S2b continue to be present (Fig. S2c) , demonstrating that DOX is chemically conjugated on the surface of the magnetite nanoparticles. On application of an external magnetic field to the container with the Fe 3 O 4 -DOX/pSiO 2 -PEG core/shell nanoparticles, the nanoparticles are attracted towards the magnet and attached on the wall of the container in close proximity of the magnet and the dispersion becomes clear (Fig.S3a) .
Removal of the external magnetic field and shaking leads to the complete recovery of the dispersion (Fig.S3b) , confirming that the prepared DOX-loaded magnetic delivery system is sensitive to an external magnetic field and shows superparamagnetic property.
The other merit of converting dense silica shell to porous one lies in increased magnetization Cytotoxicity of the FA modified Fe 3 O 4 -DOX/pSiO 2 -PEG core/shell nanoparticles is higher than that of the corresponding nanoparticles without FA modification, indirectly confirming the specific uptake of the FA-targeted drug delivery system by HeLa cells via receptor-mediated 
